Teladoc Health, Inc. provides business-to-business virtual health care services in the United States and internationally. The company is headquartered in Purchase, New York.
| Revenue (TTM) | $2.49B |
| Gross Profit (TTM) | $1.72B |
| EBITDA | $64.56M |
| Operating Margin | -5.68% |
| Return on Equity | -13.00% |
| Return on Assets | -3.22% |
| Revenue/Share (TTM) | $13.93 |
| Book Value | $7.21 |
| Price-to-Book | 0.88 |
| Price-to-Sales (TTM) | 0.44 |
| EV/Revenue | 0.569 |
| EV/EBITDA | 6.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -4.00% |
| Shares Outstanding | $181.68M |
| Float | $180.43M |
| % Insiders | 0.74% |
| % Institutions | 87.76% |
Volatility is currently expanding
NEW YORK, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release third quarter 2026 results on Wednesday, October 28, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
In the closing of the recent trading day, Teladoc (TDOC) stood at $6, denoting a +1.35% move from the preceding trading day.
TDOC expands Solo with AI tools that streamline virtual assessments and clinical documentation, targeting simpler workflows for hospitals.
The latest trading day saw Teladoc (TDOC) settling at $5.56, representing a -3.64% change from its previous close.
New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflows New SoloVitals and SoloScribe capabilities bring contactless vitals and ambient documentation directly into clinical workflows
Teladoc (TDOC) reached $5.75 at the closing of the latest trading day, reflecting a -2.38% change compared to its last close.
Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026 Jonathan Dorfman to be promoted to Chief Legal Officer and Secretary effective November 2, 2026
Teladoc (TDOC) closed the most recent trading day at $6.13, moving 3.46% from the previous trading session.
Teladoc (TDOC) concluded the recent trading session at $6.28, signifying a -2.33% move from its prior day's close.
TDOC's Integrated Care is driving profitability as chronic care gains traction, potentially making it the company's key earnings driver.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on TDOC and any ticker you trade — then tracks every position and per-strategy win rate.
